Loading…
Loading…
CVS · NYSE · Healthcare
“The astronomical P/E ratio of 52.4 against modest earnings suggests the market has priced in growth that prudent analysis cannot justify.”
— In the voice of Graham
Project future earnings using analyst estimates and historical growth rates. Model 5-year earnings trajectories.
Market Cap
$92.69B
P/E Ratio
52.43
Forward P/E
—
EPS
$1.40
PEG Ratio
0.67
Book Value
$59.36
Dividend Yield
3.67%
Profit Margin
0.44%
ROE
2.35%
Use the interactive growth projection with pre-loaded data for CVS Health Corp. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for CVS: